Overview

A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis Pain

Status:
Not yet recruiting
Trial end date:
2025-06-10
Target enrollment:
Participant gender:
Summary
This is dose-finding study of GSK3858279 in participants with moderate to severe knee osteoarthritis (OA) pain. The purpose of this study is to investigate and provide the data necessary to select the optimal effective and safe dose(s) of GSK3858279.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline